Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition

Digestive and Liver Disease

Volumn 37, Issue 1, 2005, Pages 44-50

  Goossens, Dominique ^a   Jonkers, D ^a   Russel, M ^a   Thijs, A ^a   van den Bogaard, A ^a   Stobberingh, E ^a   Stockbrugger R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastric acid inhibition; L. plantarum 299v; Probiotics

Indexed keywords

PANTOPRAZOLE; PLACEBO; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; FATTY ACID; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; OMEPRAZOLE; SULFOXIDE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FECES ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LACTOBACILLUS PLANTARUM; MALE; NONHUMAN; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH PH; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FECES; MICROBIOLOGY; MIDDLE AGED; PH; STOMACH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; FATTY ACIDS; FECES; FEMALE; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; OMEPRAZOLE; PROBIOTICS; STOMACH; SULFOXIDES;

EID: 15844429408     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.07.018     Document Type: Article

References (31)

1. Havenaar R, Ten Brink B, Huis in 't Veld J. Selection of strains for probiotic use. In: Hall CA, editor. Probiotics, the scientific basis. London; 1992. p. 209-24.
2. F. Cremonini S. Di Caro E.C. Nista F. Bartolozzi G. Capelli G. Gasbarrini et al. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea Aliment Pharmacol Ther 16 2002 1461-1467
3. W. Kruis E. Schutz P. Fric B. Fixa G. Judmaier M. Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 1997 853-858
4. P. Gionchetti F. Rizzello A. Venturi P. Brigidi D. Matteuzzi G. Bazzocchi et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial Gastroenterology 119 2000 305-309
5. S. Nobaek M.L. Johansson G. Molin S. Ahrne B. Jeppsson Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 95 2000 1231-1238
6. J.R. Saltzman R.M. Russell B. Golner S. Barakat G.E. Dallal B.R. Goldin A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance Am J Clin Nutr 69 1999 140-146
7. C. Felley I. Corthesy-Theulasz J. Blanco Rivero Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man Eur J Gastroenterol Hepatol 13 2001 25-29
8. A.C. Ouwehand S. Salminen E. Isolauri Probiotics: An overview of beneficial effects Antonie van Leeuwenhoek 82 2002 279-289
9. B.R. Goldin L. Swenson J. Dwyer M. Sexton S.L. Gorbach Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes J Natl Cancer Inst 64 1980 255-261
10. W.H. Holzapfel P. Haberer J. Snel U. Schillinger J. Huis in 't Veld Overview of gut flora and probiotics Int J Food Microbiol 41 2001 85-101
11. G.L. Simon S.L. Gorbach Intestinal flora in health and disease Gastroenterology 86 1984 174-193
12. G.M. Houben J. Hooi W. Hameeteman R.W. Stockbrugger Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo Aliment Pharmacol Ther 9 1995 649-654
13. R.A. Giannella S.A. Broitman N. Zamcheck Gastric acid barrier to ingested microorganisms in man: Studies in vivo and in vitro Gut 13 1972 251-256
14. C.N. Jacobsen V. Rosenfeldt-Nielsen A.E. Hayford P.L. Moller K.F. Michaelsen A. Paerregaard et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans Appl Environ Microbiol 65 1999 4949-4956
15. B.R. Goldin S.L. Gorbach M. Saxelin S. Barakat L. Gualtieri S. Salminen Survival of Lactobacillus species (strain GG) in human gastrointestinal tract Dig Dis Sci 37 1992 121-128
16. L.J. O'Donnell J. Virjee K.W. Heaton Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate Br Med J 300 1990 439-440
17. D. Goossens D. Jonkers M. Russel E. Stobberingh A. Van Den Bogaard R. Stockbrugger The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: A placebo-controlled study on the onset and duration of effects Aliment Pharmacol Ther 18 2003 495-505
18. A.E. van den Bogaard M.J. Hazen C.P. van Boven Quantitative gas chromatographic analysis of volatile fatty acids in spent culture media and body fluids J Clin Microbiol 23 1986 523-530
19. M.L. Johansson S. Nobaek A. Berggren M. Nyman I. Bjorck S. Ahrne et al. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats Int J Food Microbiol 42 1998 29-38
20. D.M. Jonkers E.E. Stobberingh G.M.P. Houben R.W. Stockbrugger The influence of long-term treatment with omeprazole on changes in faecal aerobic flora Gastroenterology 106 Suppl 4 1994 A101
21. A.M. Berggren I.M.E. Bjork E.M.G.L. Nyman Short-chain fatty acids content and pH in caecum of rats given various sources of carbohydrates J Sci Food Agric 63 1993 397-406
22. R. Tutuian P.O. Katz W. Bochenek D.O. Castell Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers Aliment Pharmacol Ther 16 2002 829-836
23. S.S. Harwig L. Tan X.D. Qu Y. Cho P.B. Eisenhauer R.I. Lehrer Bactericidal properties of murine intestinal phospholipase A2 J Clin Invest 95 1995 603-610
24. T. Peeters G. Vantrappen The Paneth cell: A source of intestinal lysozyme Gut 16 1975 553-558
25. S. Drouault G. Corthier S.D. Ehrlich P. Renault Survival, physiology, and lysis of Lactococcus lactis in the digestive tract Appl Environ Microbiol 65 1999 4881-4886
26. H. Koop S. Kuly M. Flug R. Eissele H. Monnikes K. Rose et al. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects Eur J Gastroenterol Hepatol 8 1996 915-918
27. A. Hannan J. Weil C. Broom R.P. Walt Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles Aliment Pharmacol Ther 6 1992 373-380
28. M. Hartmann U. Theiss R. Huber R. Luhmann H. Bliesath W. Wurst et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole Aliment Pharmacol Ther 10 1996 359-366
29. S. Mussig L. Witzel R. Luhmann A. Schneider Morning and evening administration of pantoprazole: A study to compare the effect on 24-hour intragastric pH Eur J Gastroenterol Hepatol 9 1997 599-602
30. D. Jonkers E. Stobberingh R. Stockbrugger Omeprazole inhibits growth of gram-positive and gram-negative bacteria including Helicobacter pylori in vitro J Antimicrob Chemother 37 1996 145-150
31. S.M. Cheer A. Prakash D. Faulds H.M. Lamb Pantoprazole: An update of its pharmacological properties and therapeutic use in the management of acid-related disorders Drugs 63 2003 101-133